Región del Biobío
Este organismo compró $298.296.004.113 en 32.695 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos anti infecciosos / Antibióticos y le compró principalmente a Renta Nacional Compania de Seguros Generales S.A..
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $2672,8 M |
| 2025 | $5969,9 M |
| 2024 | $6612,2 M |
| 2023 | $5526,4 M |
| 2022 | $5687,7 M |
| 2021 | $4429,1 M |
| 2020 | $4409,6 M |
| 2019 | $4050,6 M |
| 2018 | $3752,2 M |
| 2017 | $3617,8 M |
| 2016 | $2773,6 M |
| 2015 | $2444,6 M |
| 2014 | $1952,7 M |
| 2013 | $166,6 mil M |
| 2012 | $75,4 mil M |
| 2011 | $762,2 M |
| 2010 | $329 M |
| 2009 | $453,1 M |
| 2008 | $370 M |
| 2007 | $416 M |
| 2006 | $87,5 M |
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 2421-507-SE26 | 07-05-2026 | Laboratorio C&d Pharma Limitada | Recepcion Conforme | $517.650 |
| 2421-503-SE26 | 07-05-2026 | Reutter Limitada | Recepcion Conforme | $1.218.484 |
| 2421-517-CM26 | 07-05-2026 | Hospitalia Productos Medicos SpA | Recepcion Conforme | $2.380.000 |
| 2421-509-SE26 | 07-05-2026 | Laboratorio C&d Pharma Limitada | Recepcion Conforme | $345.100 |
| 2421-510-SE26 | 07-05-2026 | Insuamérica SpA | Recepcion Conforme | $928.200 |
| 2421-506-SE26 | 07-05-2026 | Laboratorios Andromaco S.A. | Recepcion Conforme | $642.600 |
| 2421-505-SE26 | 07-05-2026 | Insuamérica SpA | Recepcion Conforme | $773.500 |
| 2421-511-SE26 | 07-05-2026 | Ethon Pharmaceuticals Ltda. | Aceptada | $247.044 |
| 2421-508-SE26 | 07-05-2026 | Laboratorio Homeopatia Alemana Knop Limitada | Recepcion Conforme | $1.309.000 |
| 2421-471-SE26 | 04-05-2026 | Alembic Pharmaceuticals SpA | Recepcion Conforme | $215.271 |
| 2421-475-SE26 | 04-05-2026 | Opko Chile S.A. | Recepcion Conforme | $2.248.719 |
| 2421-484-SE26 | 04-05-2026 | Opko Chile S.A. | Recepcion Conforme | $2.741.641 |
| 2421-502-AG26 | 04-05-2026 | Alatheia Medical SpA | Recepcion Conforme | $6.621.517 |
| 2421-478-AG26 | 04-05-2026 | Guillermo Harding y Compania Limitada | Recepcion Conforme | $428.400 |
| 2421-483-SE26 | 04-05-2026 | Ethon Pharmaceuticals Ltda. | Recepcion Conforme | $2.592.653 |
| 2421-476-SE26 | 04-05-2026 | Laboratorio Pasteur S.A. | Recepcion Conforme | $1.356.600 |
| 2421-474-SE26 | 04-05-2026 | Laboratorio Chile S.A. | Recepcion Conforme | $4.403.000 |
| 2421-479-AG26 | 04-05-2026 | Laboratorio Chile S.A. | Recepcion Conforme | $856.800 |
| 2421-482-SE26 | 04-05-2026 | Laboratorios Andromaco S.A. | Recepcion Conforme | $671.160 |
| 2421-472-SE26 | 04-05-2026 | Ethon Pharmaceuticals Ltda. | Recepcion Conforme | $4.649.392 |
| 2421-500-CM26 | 04-05-2026 | Comercializadora San Jeronimo SpA | Recepcion Conforme | $5.940.000 |
| 2421-487-SE26 | 30-04-2026 | Ethon Pharmaceuticals Ltda. | Aceptada | $124.950 |
| 2421-481-SE26 | 30-04-2026 | Ethon Pharmaceuticals Ltda. | Recepcion Conforme | $730.148 |
| 2421-499-SE26 | 30-04-2026 | Ethon Pharmaceuticals Ltda. | Recepcion Conforme | $813.746 |
| 2421-480-SE26 | 30-04-2026 | Difem Laboratorios S.A. | Recepcion Conforme | $130.930 |
| 2421-488-SE26 | 30-04-2026 | Laboratorios Andromaco S.A. | Recepcion Conforme | $556.325 |
| 2421-501-AG26 | 30-04-2026 | Farmaceutica Insuval S.A. | Recepcion Conforme | $99.960 |
| 2421-486-SE26 | 30-04-2026 | Herrera y Compania Limitada | Recepcion Conforme | $2.974.984 |
| 2421-477-CM26 | 29-04-2026 | Gasco S.A. | Aceptada | $13.164.720 |
| 2421-465-SE26 | 28-04-2026 | Mdc Health SpA | Recepcion Conforme | $3.927.000 |
